Testosterone, cardiovascular disease and the metabolic syndrome.
about
Erectile dysfunction and central obesity: an Italian perspectiveAdverse effects of testosterone replacement therapy: an update on the evidence and controversyInfluence of androgens on circulating adiponectin in male and female rodentsPatient satisfaction with testosterone replacement therapies: the reasons behind the choicesTestosterone and Voluntary Exercise, Alone or Together Increase Cardiac Activation of AKT and ERK1/2 in Diabetic Rats.Risk factors for eosinophilic esophagitis.Wasting syndrome with deep bradycardia as presenting manifestation of long-standing severe male hypogonadotropic hypogonadism: a case series.Testosterone and cardiovascular risk.Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis.Androgen Deficiency and Erectile Dysfunction in Patients with Type 2 Diabetes.Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.Testosterone and metabolic syndrome.Risk Factors for Hypogonadism in Male Patients with Type 2 DiabetesHow to recognize late-onset hypogonadism in men with sexual dysfunction.Risks and benefits of late onset hypogonadism treatment: an expert opinion.Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men.Angiotensin-converting enzymes play a dominant role in fertility.Androgen Receptor Gene CAG Repeat Polymorphism Regulates the Metabolic Effects of Testosterone Replacement Therapy in Male Postsurgical Hypogonadotropic HypogonadismHormonal modulation in aging patients with erectile dysfunction and metabolic syndrome.Off label therapies for testosterone replacement.Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.Metabolic syndrome and prostate abnormalities in male subjects of infertile couples.Androgen regulation of prostate cancer: where are we now?Hormonal effects on blood vessels.Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.The effect of testosterone on cardiovascular disease: a critical review of the literature.Testosterone, aging and survival: biomarker or deficiencyCardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis.Testosterone and cardiovascular disease--the controversy and the facts.Update on Testosterone Replacement Therapy in Hypogonadal Men.Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation.Prognostic Value of Dehydroepiandrosterone Sulfate for Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis.Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study.Low testosterone and non-alcoholic fatty liver disease: Evidence for their independent association in men with chronic spinal cord injury.Relationship between Testicular Volume and Conventional or Nonconventional Sperm Parameters.Testosterone and β-oestradiol prevent inward remodelling of rat small mesenteric arteries: role of NO and transglutaminase.Seminal, ultrasound and psychobiological parameters correlate with metabolic syndrome in male members of infertile couples.
P2860
Q22241096-9C0C6EB9-EC77-4F26-B6F0-083BBA64381CQ24564836-2214AE15-70A4-462B-8F32-E3A593582123Q27314775-277DE994-A567-4CA3-B184-F4E6B0077B53Q28304192-FFAEEDA6-3AC1-4717-A51B-18900381ECDBQ30100987-57D5707C-31AB-4F90-80A6-890D46AE8A88Q31170219-602F4EDC-8105-45C9-A300-127B3ED5686FQ34266044-A042D862-F160-465F-A52D-9ED373C8E46FQ34332054-8725179B-D80D-4921-8B75-FF7000A93E24Q34408679-53D1D01A-E91E-4FD5-B223-FC2C2C9A059EQ35202889-2B47BC74-8FFE-40DB-959A-163CE5CF3F48Q35871552-94A7759C-05E7-4F5A-A4F2-7AFD5662272AQ36287950-75C6FB32-71CE-414A-9042-91BFE5D971A0Q36293071-64813D3F-F60E-4968-BB1B-07B892442F3AQ36661316-FDD5ECFD-D62A-428D-A7B0-9DAD3C999032Q37074425-7FA08BCD-9D58-43ED-9BFC-958B44751C9FQ37165019-D8BAD0B4-2EDE-45F3-A579-36255FFC895CQ37194827-57B9284C-1778-4D53-A757-3018CD1B77DBQ37291414-87AB27E6-BFA9-49AB-8E3B-05CFB680D915Q37422378-74DDAF7E-0FC8-45EF-BB39-3082CB4C110FQ37465843-AEE201A7-8B93-4BB2-97A4-FE0CCADC98A7Q37531056-564B3EC3-7747-4012-A631-A91DEC2AFB92Q37618958-8E580F91-AFD5-4531-8C79-4D5C5F2D0403Q37639222-9E996A13-ACB0-44AF-B988-71720D53B737Q37836264-E0068D05-7A75-45AC-B0E8-EBC23D63FDACQ37980611-24FD232B-12B8-475B-A14D-5EB3444105FCQ38071012-04500837-AB8F-4E62-9645-79EAD96D69E6Q38133734-BC5CFD50-455D-42C8-9AE9-16666ABFF808Q38190531-F22D79D5-0AD3-4A4C-A45B-43593B9B1117Q38203765-4D2666D6-D588-4DA8-BD3B-06643C8588E8Q38241416-B8A0CF2C-9629-4E27-BE23-29517D6DED89Q38364486-99353C85-FF27-4492-8DBC-BAF5AFDA56EAQ38528376-8D84EAEE-C2ED-41E3-8EB8-6C3C71F936B3Q39095837-84AA805B-AFA8-4A8C-943F-9A8FE34ECDB9Q39160111-3E2E1BDB-20B9-49CB-9DD3-11AAB3880E86Q39286914-DAB4D6F0-94A8-4D9B-9035-4CC558E31F37Q41470207-CCF9E62B-249E-446F-B01A-F9F8E49886C8Q42371319-92E2A571-CE96-4484-932B-D7C4493694D5Q42971253-A5B40421-14ED-47A1-9C1D-CC205C6C6FD3Q44630577-CF285442-611C-44BE-ABD2-DEA6620D0025Q44956849-64B228E7-42EE-4C46-8D09-93FAF18B691A
P2860
Testosterone, cardiovascular disease and the metabolic syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Testosterone, cardiovascular disease and the metabolic syndrome.
@en
Testosterone, cardiovascular disease and the metabolic syndrome.
@nl
type
label
Testosterone, cardiovascular disease and the metabolic syndrome.
@en
Testosterone, cardiovascular disease and the metabolic syndrome.
@nl
prefLabel
Testosterone, cardiovascular disease and the metabolic syndrome.
@en
Testosterone, cardiovascular disease and the metabolic syndrome.
@nl
P2093
P1476
Testosterone, cardiovascular disease and the metabolic syndrome.
@en
P2093
Edoardo Mannucci
Giulia Rastrelli
Linda Vignozzi
P304
P356
10.1016/J.BEEM.2010.07.002
P577
2011-04-01T00:00:00Z